Small-Molecule TLR8 Antagonists via Structure-Based Rational Design (Cell Chemical Biology)

Structure-based rational design led to discovery of six exceptionally potent compounds with ~pM IC50 values. Two new X-ray crystallographic structures validated the contacts within the binding pocket. TLR8-transgenic mice further demonstrated these TLR8 inhibitors` high efficacy, suggesting strong therapeutic potential against autoimmune disorders.